We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

135 hedge funds and large institutions have $859M invested in Cogent Biosciences in 2022 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 53 increasing their positions, 37 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,929% more call options, than puts

Call options by funds: $704K | Put options by funds: $14K

43% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 37

5% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 21

1% more funds holding

Funds holding: 134 → 135 (+1)

8.57% less ownership

Funds ownership: 115.69% → 107.12% (-8.6%)

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

24% less capital invested

Capital invested by funds: $1.13B → $859M (-$270M)

Holders
135
Holders Change
+1
Holders Change %
+0.75%
% of All Funds
2.17%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.1%
New
22
Increased
53
Reduced
37
Closed
21
Calls
$704K
Puts
$14K
Net Calls
+$690K
Net Calls Change
-$418K

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$24.6M
2
Marshall Wace
Marshall Wace
United Kingdom
+$18.3M
3
LGM
Logos Global Management
California
+$13.6M
4
State Street
State Street
Massachusetts
+$10.6M
5
Citadel Advisors
Citadel Advisors
Florida
+$6.47M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$22M
2
APM
Avidity Partners Management
Texas
-$20.3M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$15.7M
4
BI
BVF Inc
California
-$13.6M
5
CAM
Cormorant Asset Management
Massachusetts
-$6.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
26
Kynam Capital Management
New Jersey
$9.18M -$2.37M -191,106 -19%
5VM
27
5AM Venture Management
California
$9.14M – – –
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$8.48M -$2.06M -166,613 -19%
Assenagon Asset Management
29
Assenagon Asset Management
Luxembourg
$8.07M -$3.6M -290,365 -29%
Goldman Sachs
30
Goldman Sachs
New York
$7.46M -$1.19M -96,251 -13%
Northern Trust
31
Northern Trust
Illinois
$6.27M +$88.4K +7,132 +1%
BC
32
Boxer Capital
California
$6.07M +$1.24M +100,000 +24%
PIM
33
Platinum Investment Management
Australia
$5.91M – – –
NLVP
34
New Leaf Venture Partners
New York
$5.8M – – –
Morgan Stanley
35
Morgan Stanley
New York
$5.68M -$913K -73,682 -13%
Walleye Capital
36
Walleye Capital
New York
$5.13M +$3.84M +309,955 +231%
ECM
37
ExodusPoint Capital Management
New York
$4.67M +$5M +403,625 New
Rafferty Asset Management
38
Rafferty Asset Management
New York
$3.74M +$1.42M +114,511 +55%
Connor, Clark & Lunn Investment Management (CC&L)
39
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$3.16M +$157K +12,689 +5%
Bank of America
40
Bank of America
North Carolina
$3.02M +$876K +70,679 +37%
Bank of New York Mellon
41
Bank of New York Mellon
New York
$2.99M +$61.3K +4,946 +2%
JP Morgan Chase
42
JP Morgan Chase
New York
$2.79M +$156K +12,578 +5%
Macquarie Group
43
Macquarie Group
Australia
$2.66M – – –
UBS Group
44
UBS Group
Switzerland
$2.51M +$2.29M +184,452 +565%
SSA
45
Schonfeld Strategic Advisors
New York
$2.37M +$1.43M +115,617 +129%
Millennium Management
46
Millennium Management
New York
$2.31M +$2.48M +200,182 New
AG
47
Algert Global
California
$2.24M +$1.08M +87,190 +82%
AAA
48
Affinity Asset Advisors
New York
$2.23M +$483K +38,977 +25%
HS
49
HighVista Strategies
Massachusetts
$2.13M +$806K +65,049 +55%
Barclays
50
Barclays
United Kingdom
$2.07M +$387K +31,236 +21%
1
2
3 4 5

COGT Hedge Fund Activity: Q4 2022 in Review

135 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q4 2022, worth a combined $859M — down 24% from $1.13B a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new COGT positions and 21 closed out — a net gain of 1 holder — while 53 added to existing stakes and 37 trimmed.

The largest buyer was RA Capital Management, adding an estimated $24.6M. The largest seller was Janus Henderson Group, cutting an estimated $22M.

  • 135 institutional investors held Cogent Biosciences (COGT) as of Q4 2022, up from 134 in Q3 2022.
  • Funds reported $859M of Cogent Biosciences stock for Q4 2022, down 24% quarter-over-quarter.
  • 22 funds opened new Cogent Biosciences positions in Q4 2022 and 21 closed out, a net change of +1 holder.
  • The largest Cogent Biosciences buyer in Q4 2022 was RA Capital Management, an estimated $24.6M added.
  • The largest Cogent Biosciences seller in Q4 2022 was Janus Henderson Group, an estimated $22M sold.

Based on aggregated 13F filings for Q4 2022.